Literature DB >> 5662580

The effect of peripheral lymphocytes from patients with inflammatory joint disease on human target cells in vitro.

I C MacLennan, G Loewi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5662580      PMCID： PMC1578910     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  8 in total

1.  THE DEVELOPMENT OF LARGE IMMATURE MONONUCLEAR CELLS IN MIXED LEUKOCYTE CULTURES.

Authors:  B BAIN; M R VAS; L LOWENSTEIN
Journal:  Blood       Date:  1964-01       Impact factor: 22.113

2.  THE SPECIFICITY OF THE CYTOLYTIC EFFECT OF SENSITIZED LYMPHOID CELLS IN VITRO.

Authors:  W ROSENAU; H D MOON
Journal:  J Immunol       Date:  1964-12       Impact factor: 5.422

3.  Effects of phytohemagglutinin on rat and normal and leukemic human blood cells.

Authors:  R SCHREK; Y RABINOWITZ
Journal:  Proc Soc Exp Biol Med       Date:  1963-05

Review 4.  A theory of the action of cancer chemotherapeutic drugs.

Authors:  S Rose
Journal:  Clin Exp Immunol       Date:  1967-05       Impact factor: 4.330

5.  Quantitative studies on phytohaemagglutinin-induced cytotoxicity by human lymphocytes against homologous cells in tissue culture.

Authors:  G Holm; P Perlmann
Journal:  Immunology       Date:  1967-05       Impact factor: 7.397

6.  STUDIES ON MONONUCLEAR CELLS OBTAINED FROM SYNOVIAL FLUID OF PATIENTS WITH DIFFERENT TYPES OF ARTHRITIS. CYTOTOXIC EFFECT ON TISSUE-CULTURED HUMAN FIBROBLASTS.

Authors:  H HEDBERG; B KAELLEN
Journal:  Acta Pathol Microbiol Scand       Date:  1964

7.  Destruction of human cells in tissue culture by lymphocytes from patients with systemic lupus erythematosus.

Authors:  T G Trayanova; V V Sura; G J Svet-Moldavsky
Journal:  Lancet       Date:  1966-02-26       Impact factor: 79.321

8.  Cytotoxic potential of stimulated human lymphocytes.

Authors:  G Holm; P Perlmann
Journal:  J Exp Med       Date:  1967-04-01       Impact factor: 14.307
  8 in total
  13 in total

1.  Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbits IgG.

Authors:  I C MacLennan; G E Connell; F M Gotch
Journal:  Immunology       Date:  1974-02       Impact factor: 7.397

2.  A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes.

Authors:  I C MacLennan; G Loewi; A Howard
Journal:  Immunology       Date:  1969-12       Impact factor: 7.397

3.  The cytotoxic activity of mononuclear cells from joint fluid.

Authors:  I C Maclennan; G Loewi
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

4.  [In vitro study of the pathogenesis of primary chronic polyarthritis by means of migration inhibition test].

Authors:  W Rothenberger; H G Thiele
Journal:  Klin Wochenschr       Date:  1970-11-01

5.  A study of the effects of anti-macrophage sera.

Authors:  G Loewi; A Temple; A P Nind; M Axelrad
Journal:  Immunology       Date:  1969-01       Impact factor: 7.397

6.  Interaction in vitro between synovial cells and autologous lymphocytes and sera from arthritis patients.

Authors:  T Ghose; J F Woodbury; M M Hansell
Journal:  J Clin Pathol       Date:  1975-07       Impact factor: 3.411

7.  Spontaneous 51Cr release by isolated rat hepatocytes: an indicator of membrane damage.

Authors:  R Zawydiwski; R Duncan
Journal:  In Vitro       Date:  1978-08

Review 8.  Anti-lymphocytic antibody and autoimmune disease: a review.

Authors:  A M Denman
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

9.  Cell-mediated cytotoxicity for cultured autologous rheumatoid synovial membrane cells.

Authors:  W A Neill
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

10.  Natural killer cell activity in inflammatory joint disease.

Authors:  R D Armstrong; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.